You are here: Home » PTI Stories » National » News
Business Standard

Lupin gets USFDA nod for generic malaria drug

Press Trust of India  |  New Delhi 

Drug firm today said it has received approval from the US health regulator for Sulfate tablets, which is used to treat

The company has received final approval from the USFDA for its product which is a generic version of Concordia Pharmaceuticals, Inc's tablets, said in a statement.

The drug is indicated for the treatment of and in adults.

According to IQVIA MAT April 2018 data, Sulfate tablets had annual sales of around USD 215.3 million in the US.

Shares of today ended 0.42 per cent down at Rs 911.95 on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, July 09 2018. 16:25 IST